Two-gene mutation in a single patient

Biochemical and functional analysis for a correct interpretation of exome results

Anna Monica Bianco, Flavio Faletra, Diego Vozzi, Martina Girardelli, Alessandra Knowles, Alberto Tommasini, Giorgio Zauli, Annalisa Marcuzzi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Next-generation sequencing (NGS) has generated a large amount of sequence data with the requirement of frequent critical revisions of reported mutations. This innovative tool has proved to be effective in detecting pathogenic mutations; however, it requires a certain degree of experience to identify incidental findings. In the present study, whole exome sequencing analysis was performed for the molecular diagnosis and correct genotype/phenotype correlation between parents and a patient presenting with an atypical phenotype. In addition, mevalonic acid quantification and frequency analysis of detected variants in public databases and X-chromosome inactivation (XCI) studies on the patient's mother were performed. V377I as well as the S135L mutations were identified on the mevalonate kinase deficiency gene and the levels of mevalonic acid in the patient were 5,496 μg/ml. A D59G variation, reported in ESP6500 in two healthy individuals, was found on the Martin Probst syndrome gene (RAB40AL). Based on XCI studies on the patient's mother, it is likely that RAB40AL escapes XCI, while still remaining balanced. In conclusion, the results of the present study indicated that the Martin Probst syndrome is an X-linked condition, which is probably not caused by RAB40AL mutations. Although NGS is a powerful tool to identify pathogenic mutations, the analysis of genetic data requires expert critical revision of all detected variants.

Original languageEnglish
Pages (from-to)6128-6132
Number of pages5
JournalMolecular Medicine Reports
Volume12
Issue number4
DOIs
Publication statusPublished - 1 Oct 2015
Externally publishedYes

Fingerprint

Exome
Functional analysis
Chromosomes
Mevalonic Acid
Genes
X Chromosome Inactivation
mevalonate kinase
Mutation
Mevalonate Kinase Deficiency
Mothers
Incidental Findings
Genetic Association Studies
Parents
Databases
Phenotype

Keywords

  • Genotype-phenotype
  • Mevalonate
  • Mevalonate kinase deficiency
  • RAB40AL
  • Rare disease

ASJC Scopus subject areas

  • Biochemistry
  • Cancer Research
  • Genetics
  • Molecular Biology
  • Molecular Medicine
  • Oncology
  • Medicine(all)

Cite this

Two-gene mutation in a single patient : Biochemical and functional analysis for a correct interpretation of exome results. / Bianco, Anna Monica; Faletra, Flavio; Vozzi, Diego; Girardelli, Martina; Knowles, Alessandra; Tommasini, Alberto; Zauli, Giorgio; Marcuzzi, Annalisa.

In: Molecular Medicine Reports, Vol. 12, No. 4, 01.10.2015, p. 6128-6132.

Research output: Contribution to journalArticle

Bianco, AM, Faletra, F, Vozzi, D, Girardelli, M, Knowles, A, Tommasini, A, Zauli, G & Marcuzzi, A 2015, 'Two-gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results', Molecular Medicine Reports, vol. 12, no. 4, pp. 6128-6132. https://doi.org/10.3892/mmr.2015.4215
Bianco, Anna Monica ; Faletra, Flavio ; Vozzi, Diego ; Girardelli, Martina ; Knowles, Alessandra ; Tommasini, Alberto ; Zauli, Giorgio ; Marcuzzi, Annalisa. / Two-gene mutation in a single patient : Biochemical and functional analysis for a correct interpretation of exome results. In: Molecular Medicine Reports. 2015 ; Vol. 12, No. 4. pp. 6128-6132.
@article{70c666853a8342259ee569cda387c95f,
title = "Two-gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results",
abstract = "Next-generation sequencing (NGS) has generated a large amount of sequence data with the requirement of frequent critical revisions of reported mutations. This innovative tool has proved to be effective in detecting pathogenic mutations; however, it requires a certain degree of experience to identify incidental findings. In the present study, whole exome sequencing analysis was performed for the molecular diagnosis and correct genotype/phenotype correlation between parents and a patient presenting with an atypical phenotype. In addition, mevalonic acid quantification and frequency analysis of detected variants in public databases and X-chromosome inactivation (XCI) studies on the patient's mother were performed. V377I as well as the S135L mutations were identified on the mevalonate kinase deficiency gene and the levels of mevalonic acid in the patient were 5,496 μg/ml. A D59G variation, reported in ESP6500 in two healthy individuals, was found on the Martin Probst syndrome gene (RAB40AL). Based on XCI studies on the patient's mother, it is likely that RAB40AL escapes XCI, while still remaining balanced. In conclusion, the results of the present study indicated that the Martin Probst syndrome is an X-linked condition, which is probably not caused by RAB40AL mutations. Although NGS is a powerful tool to identify pathogenic mutations, the analysis of genetic data requires expert critical revision of all detected variants.",
keywords = "Genotype-phenotype, Mevalonate, Mevalonate kinase deficiency, RAB40AL, Rare disease",
author = "Bianco, {Anna Monica} and Flavio Faletra and Diego Vozzi and Martina Girardelli and Alessandra Knowles and Alberto Tommasini and Giorgio Zauli and Annalisa Marcuzzi",
year = "2015",
month = "10",
day = "1",
doi = "10.3892/mmr.2015.4215",
language = "English",
volume = "12",
pages = "6128--6132",
journal = "Molecular Medicine Reports",
issn = "1791-2997",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - Two-gene mutation in a single patient

T2 - Biochemical and functional analysis for a correct interpretation of exome results

AU - Bianco, Anna Monica

AU - Faletra, Flavio

AU - Vozzi, Diego

AU - Girardelli, Martina

AU - Knowles, Alessandra

AU - Tommasini, Alberto

AU - Zauli, Giorgio

AU - Marcuzzi, Annalisa

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Next-generation sequencing (NGS) has generated a large amount of sequence data with the requirement of frequent critical revisions of reported mutations. This innovative tool has proved to be effective in detecting pathogenic mutations; however, it requires a certain degree of experience to identify incidental findings. In the present study, whole exome sequencing analysis was performed for the molecular diagnosis and correct genotype/phenotype correlation between parents and a patient presenting with an atypical phenotype. In addition, mevalonic acid quantification and frequency analysis of detected variants in public databases and X-chromosome inactivation (XCI) studies on the patient's mother were performed. V377I as well as the S135L mutations were identified on the mevalonate kinase deficiency gene and the levels of mevalonic acid in the patient were 5,496 μg/ml. A D59G variation, reported in ESP6500 in two healthy individuals, was found on the Martin Probst syndrome gene (RAB40AL). Based on XCI studies on the patient's mother, it is likely that RAB40AL escapes XCI, while still remaining balanced. In conclusion, the results of the present study indicated that the Martin Probst syndrome is an X-linked condition, which is probably not caused by RAB40AL mutations. Although NGS is a powerful tool to identify pathogenic mutations, the analysis of genetic data requires expert critical revision of all detected variants.

AB - Next-generation sequencing (NGS) has generated a large amount of sequence data with the requirement of frequent critical revisions of reported mutations. This innovative tool has proved to be effective in detecting pathogenic mutations; however, it requires a certain degree of experience to identify incidental findings. In the present study, whole exome sequencing analysis was performed for the molecular diagnosis and correct genotype/phenotype correlation between parents and a patient presenting with an atypical phenotype. In addition, mevalonic acid quantification and frequency analysis of detected variants in public databases and X-chromosome inactivation (XCI) studies on the patient's mother were performed. V377I as well as the S135L mutations were identified on the mevalonate kinase deficiency gene and the levels of mevalonic acid in the patient were 5,496 μg/ml. A D59G variation, reported in ESP6500 in two healthy individuals, was found on the Martin Probst syndrome gene (RAB40AL). Based on XCI studies on the patient's mother, it is likely that RAB40AL escapes XCI, while still remaining balanced. In conclusion, the results of the present study indicated that the Martin Probst syndrome is an X-linked condition, which is probably not caused by RAB40AL mutations. Although NGS is a powerful tool to identify pathogenic mutations, the analysis of genetic data requires expert critical revision of all detected variants.

KW - Genotype-phenotype

KW - Mevalonate

KW - Mevalonate kinase deficiency

KW - RAB40AL

KW - Rare disease

UR - http://www.scopus.com/inward/record.url?scp=84940508789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940508789&partnerID=8YFLogxK

U2 - 10.3892/mmr.2015.4215

DO - 10.3892/mmr.2015.4215

M3 - Article

VL - 12

SP - 6128

EP - 6132

JO - Molecular Medicine Reports

JF - Molecular Medicine Reports

SN - 1791-2997

IS - 4

ER -